Printer Friendly

NEW DEVELOPMENTS IN ENDOSCOPIC SURGERY TO BE ANNOUNCED BY JOHNSON & JOHNSON SUBSIDIARY

 NEW DEVELOPMENTS IN ENDOSCOPIC SURGERY
 TO BE ANNOUNCED BY JOHNSON & JOHNSON SUBSIDIARY
 A press conference announcing one of the most significant technical and business developments to date in endoscopic surgery will be held Wednesday, Sept. 9. The conference will detail new research and marketing initiatives by Ethicon Endo-Surgery, a Johnson & Johnson company. Panelists include Robert Croce, worldwide president of Ethicon Endo-Surgery, and leading surgeons.
 Impact of the Johnson & Johnson announcement will reach into every hospital and operating room across the country and around the world.
 TIME: 9:30 a.m. Continental breakfast
 10 a.m. Press conference begins
 DATE: Wednesday, Sept. 9, 1992
 LOCATION: Hotel Macklowe
 145 West 44th Street
 New York City
 SPECIAL: B-roll, press releases, photos
 All attendees will be asked to provide a business card or other means of identification.
 CONTACT: RSVP immediately to, Peter Steinerman, or Christine Mathis of Ruder-Finn, 212-715-1678 or 212-715-1590, for Johnson & Johnson.
 -0- 9/8/92


CO: Johnson & Johnson; Ethicon Endo-Surgery ST: New York IN: HEA SU: PDT

PS -- NY005 -- 6888 09/08/92 10:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 8, 1992
Words:175
Previous Article:SPRINT TO GIVE AWAY ONE YEAR OF FREE LONG DISTANCE TO CELEBRITY LOOKALIKE
Next Article:CompUSA INC. AGREES TO RETAIL FULL COMPAQ COMPUTER LINE
Topics:


Related Articles
JOHNSON & JOHNSON BRIEFS ANALYSTS
LOWERING HEALTH CARE COSTS MAY DEPEND ON RESEARCH FOR NEW MEDICAL TECHNOLOGIES
NEW ENDOSCOPIC HERNIA REPAIR TECHNIQUE TO BE INTRODUCED TO NEW YORK SURGEONS
JOHNSON & JOHNSON DIVIDES ETHICON INTO TWO SEPARATE COMPANIES
AMERICAN HOME PRODUCTS ACQUIRES SYMBIOSIS CORP.
VHA SIGNS $1.2 BILLION SOLE-SOURCE AGREEMENTS FOR SUTURES, STAPLERS AND ENDOSCOPIC SURGERY PRODUCTS WITH JOHNSON & JOHNSON SUBSIDIARIES
JOHNSON & JOHNSON WINS PATENT RULING VS. U.S. SURGICAL ON CLIP APPLIER
FROST & SULLIVAN: HOSPITAL INFECTION CONTROL PRODUCTS TO TOP $1 BILLION BY 2000 AT 7.5% CAGR
JOHNSON & JOHNSON SECOND QUARTER SALES INCREASE 10.6%; EARNINGS PER SHARE UP 14.7%
CONMED Files Suit Against Johnson & Johnson for Violation of Antitrust Laws.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters